193 related articles for article (PubMed ID: 30886338)
1. Anti-HIV-1 integrase potency of methylgallate from Alchornea cordifolia using in vitro and in silico approaches.
Siwe-Noundou X; Musyoka TM; Moses V; Ndinteh DT; Mnkandhla D; Hoppe H; Tastan Bishop Ö; Krause RWM
Sci Rep; 2019 Mar; 9(1):4718. PubMed ID: 30886338
[TBL] [Abstract][Full Text] [Related]
2. Novel 4-Oxo-4,10-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic Acid Derivatives as HIV-1 Integrase Inhibitors: Synthesis, Docking Studies, Molecular Dynamics Simulation and Biological Activities.
Zadeh EE; Vahabpour R; Beirami AD; Hajimahdi Z; Zarghi A
Med Chem; 2021; 17(9):1060-1071. PubMed ID: 32901587
[TBL] [Abstract][Full Text] [Related]
3. N-hydroxy-substituted 2-aryl acetamide analogs: A novel class of HIV-1 integrase inhibitors.
Debnath U; Kumar P; Agarwal A; Kesharwani A; Gupta SK; Katti SB
Chem Biol Drug Des; 2017 Oct; 90(4):527-534. PubMed ID: 28294572
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 integrase: a target for new AIDS chemotherapeutics.
Anthony NJ
Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
[TBL] [Abstract][Full Text] [Related]
5. Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture.
Reddy MV; Rao MR; Rhodes D; Hansen MS; Rubins K; Bushman FD; Venkateswarlu Y; Faulkner DJ
J Med Chem; 1999 Jun; 42(11):1901-7. PubMed ID: 10354398
[TBL] [Abstract][Full Text] [Related]
6. 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.
Zhao XZ; Maddali K; Smith SJ; Métifiot M; Johnson BC; Marchand C; Hughes SH; Pommier Y; Burke TR
Bioorg Med Chem Lett; 2012 Dec; 22(24):7309-13. PubMed ID: 23149229
[TBL] [Abstract][Full Text] [Related]
7. Novel inhibitors of HIV-1 integration.
Witvrouw M; Van Maele B; Vercammen J; Hantson A; Engelborghs Y; De Clercq E; Pannecouque C; Debyser Z
Curr Drug Metab; 2004 Aug; 5(4):291-304. PubMed ID: 15320701
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors.
Koneru PC; Francis AC; Deng N; Rebensburg SV; Hoyte AC; Lindenberger J; Adu-Ampratwum D; Larue RC; Wempe MF; Engelman AN; Lyumkis D; Fuchs JR; Levy RM; Melikyan GB; Kvaratskhelia M
Elife; 2019 May; 8():. PubMed ID: 31120420
[TBL] [Abstract][Full Text] [Related]
9. Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids.
Nair V; Okello M
Molecules; 2015 Jul; 20(7):12623-51. PubMed ID: 26184144
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
Manyeruke MH; Olomola TO; Majumder S; Abrahams S; Isaacs M; Mautsa N; Mosebi S; Mnkandhla D; Hewer R; Hoppe HC; Klein R; Kaye PT
Bioorg Med Chem; 2015 Dec; 23(24):7521-8. PubMed ID: 26775541
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.
Jones GS; Yu F; Zeynalzadegan A; Hesselgesser J; Chen X; Chen J; Jin H; Kim CU; Wright M; Geleziunas R; Tsiang M
Antimicrob Agents Chemother; 2009 Mar; 53(3):1194-203. PubMed ID: 19104010
[TBL] [Abstract][Full Text] [Related]
12. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
[TBL] [Abstract][Full Text] [Related]
13. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
[TBL] [Abstract][Full Text] [Related]
14. Anti-HIV-1 integrase compounds from Dioscorea bulbifera and molecular docking study.
Chaniad P; Wattanapiromsakul C; Pianwanit S; Tewtrakul S
Pharm Biol; 2016; 54(6):1077-85. PubMed ID: 26864337
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of aromatic diketone derivatives as HIV-1 integrase inhibitors.
Hu L; Li Z; Wang Z; Liu G; He X; Wang X; Zeng C
Med Chem; 2015; 11(2):180-7. PubMed ID: 25173788
[TBL] [Abstract][Full Text] [Related]
16. HIV integrase inhibitory activity of Agastache rugosa.
Kim HK; Lee HK; Shin CG; Huh H
Arch Pharm Res; 1999 Oct; 22(5):520-3. PubMed ID: 10549582
[TBL] [Abstract][Full Text] [Related]
17. Diketo acids derivatives as integrase inhibitors: the war against the acquired immunodeficiency syndrome.
Henao-Mejia J; Góez Y; Patiño P; Rugeles MT
Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):255-65. PubMed ID: 18221151
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV-1 integrase activity and molecular docking of compounds from Albizia procera bark.
Panthong P; Bunluepuech K; Boonnak N; Chaniad P; Pianwanit S; Wattanapiromsakul C; Tewtrakul S
Pharm Biol; 2015; 53(12):1861-6. PubMed ID: 25868621
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV-1 integrase effect of compounds from Aglaia andamanica leaves and molecular docking study with acute toxicity test in mice.
Puripattanavong J; Tungcharoen P; Chaniad P; Pianwanit S; Tewtrakul S
Pharm Biol; 2016; 54(4):654-9. PubMed ID: 26427611
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for potential HIV-integrase inhibitors identified using pharmacophore-based virtual screening and molecular dynamics studies.
Islam MA; Pillay TS
Mol Biosyst; 2016 Mar; 12(3):982-93. PubMed ID: 26809073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]